Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4550492010 | Tepotinib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4550493017 | Tepotinib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tepotinib | est un(e) (attribut) | Antineoplastic agent (substance) | false | Inferred relationship | Some | ||
| Tepotinib | est un(e) (attribut) | Piperidine | true | Inferred relationship | Some | ||
| Tepotinib | est un(e) (attribut) | Protein-tyrosine kinase inhibitor | false | Inferred relationship | Some | ||
| Tepotinib | Has disposition (attribute) | Protein-tyrosine kinase inhibitor (disposition) | false | Inferred relationship | Some | ||
| Tepotinib | est un(e) (attribut) | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Tepotinib | est un(e) (attribut) | Mesenchymal epithelial transition inhibitor | true | Inferred relationship | Some | ||
| Tepotinib | Has disposition (attribute) | Mesenchymal epithelial transition inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing tepotinib (medicinal product) | a pour principe actif (attribut) | True | Tepotinib | Inferred relationship | Some | 1 |
| Tepotinib only product | a pour principe actif (attribut) | True | Tepotinib | Inferred relationship | Some | 1 |
| Tepotinib only product in oral dose form | a pour principe actif (attribut) | True | Tepotinib | Inferred relationship | Some | 1 |
| Product containing tepotinib in oral dose form (medicinal product form) | a pour principe actif (attribut) | True | Tepotinib | Inferred relationship | Some | 1 |
| Tepotinib hydrochloride | Is modification of (attribute) | True | Tepotinib | Inferred relationship | Some | |
| Product containing precisely tepotinib (as tepotinib hydrochloride) 225 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Tepotinib | Inferred relationship | Some | 1 |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR